Found: 12
Select item for more details and to access through your institution.
Salvage Therapy for Childhood Medulloblastoma: A Single Center Experience.
- Published in:
- Canadian Journal of Neurological Sciences, 2019, v. 46, n. 4, p. 403, doi. 10.1017/cjn.2019.39
- By:
- Publication type:
- Article
Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-35118-3
- By:
- Publication type:
- Article
An effective kinase inhibition strategy for metastatic recurrent childhood medulloblastoma.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 163, n. 3, p. 635, doi. 10.1007/s11060-023-04372-w
- By:
- Publication type:
- Article
Dynamic profiling of medulloblastoma surfaceome.
- Published in:
- Acta Neuropathologica Communications, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40478-023-01609-7
- By:
- Publication type:
- Article
Correction to: Dynamic profiling of medulloblastoma surfaceome.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Dynamic profiling of medulloblastoma surfaceome.
- Published in:
- Acta Neuropathologica Communications, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40478-023-01609-7
- By:
- Publication type:
- Article
Wnt activation as a therapeutic strategy in medulloblastoma.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-17953-4
- By:
- Publication type:
- Article
Salvage therapy for progressive, treatment-refractory or recurrent pediatric medulloblastoma: a systematic review protocol.
- Published in:
- Systematic Reviews, 2020, v. 9, n. 1, p. 1, doi. 10.1186/s13643-020-01307-8
- By:
- Publication type:
- Article
THER-14. SMALL MOLECULE INHIBITOR TARGETING SELF-RENEWAL AS A THERAPEUTIC OPTION FOR RECURRENT MEDULLOBLASTOMA.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii117, doi. 10.1093/neuonc/noz036.221
- By:
- Publication type:
- Article
MEDU-44. MUSASHI-1 IS A MASTER REGULATOR OF ABERRANT TRANSLATION IN GROUP 3 MEDULLOBLASTOMA.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii112, doi. 10.1093/neuonc/noz036.202
- By:
- Publication type:
- Article
MEDU-25. GENES PRESERVING STEM CELL STATE IN GROUP 3 MB BTICs CONTRIBUTE TO THERAPY EVASION AND RELAPSE.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii108, doi. 10.1093/neuonc/noz036.184
- By:
- Publication type:
- Article
MEDU-10. THERAPEUTIC TARGETING OF STEM CELL SELF-RENEWAL IN CHILDHOOD MEDULLOBLASTOMA: STRATEGIES FOR BLOCKING RECURRENCE.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii105, doi. 10.1093/neuonc/noz036.169
- By:
- Publication type:
- Article